Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
RemeGen ADC drug RC108 combined with PD-1 has been approved for the treatment of solid tumors in phase Ⅰb/Ⅱ clinical trial
>> article
RemeGen ADC drug RC108 combined with PD-1 has been approved for the treatment of solid tumors in phase Ⅰb/Ⅱ clinical trial
Editor:xuezhe Clicks:
0
Date:2023-6-14 12:00:14
Keyword:
ADC
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
7-ADCA reference price
Enbio: Partnered with BioNTech to advance the development of next-gene...
7-ADCA reference price
Health Network News: 7-ADCA is tight, the manufacturer raises the pric...
7-ADCA reference price
Star ADC Therapy DS-8201 approved for market in China!
Conoya sells global interest in Claudin 11.88 ADC for $18.2 billion
7-ADCA reference price
7-ADCA reference price
7-ADCA reference price
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
